Últimas noticias sobre Scilex Holding (NASDAQ:SCLX) Bolsa

Scilex Holding

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Scilex Holding Co

Macro Economic Events

News

Economics

White House Economic Adviser Singh Says Data Shows China Using Its Market Power To Gain Economic And Geopolitical Leverage; We Are Seeing Unrivaled Level And Rate Of Growth In China's Subsidies

Autodesk (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adsk#NASDAQ">ADSK</a>) recently announced AI-integrated product developments across segments to enhance performance and efficiency. It aims to simplify complexities related to the manufacturing and designing of products by introducing AI capabilities to Fusion and Alias.
<h2>Autodesk Adds AI-Powered Capabilities to Fusion</h2>
Autodesk Fusion will be integrated with new Autodesk AI-supported automation to enable time-saving. A combination of performance enhancements and the latest granular Manufacturing Dada Model API is expected to make Fusion faster. Integration with tools across the design will also become easier.
MDM API helps authorized third-party apps to feed their data into Fusion models. This helps in integrating Fusion better into existing workflows and connections with cloud and desktop tools like OpenBOM and Cideon become easier.
<div class="chart_embed">
<h3>Autodesk, Inc. Price and Consensus</h3>
<img alt="Autodesk, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/f3/1729166194.png" style="height:265px; width:587px" title="" />
Autodesk, Inc. price-consensus-chart | Autodesk, Inc. Quote
ADSK is introducing AutoConstrain in Fusion Automated Sketching. Autodesk AI will assist in analyzing and detecting intended spatial connections in project data and will provide dimensional constraints to manage design intention throughout the project.
Autodesk AI will allow users to examine 3D models through Drawing Automation and will generate 2D drawings needed to manufacture parts. This will save time.
Autodesk has launched an AI-powered Assistant in Fusion to provide real-time and on-demand expert insights related to ADSK-specific and general industry data.
ADSK is also integrating Paperless Parts and Avnet plugins into Fusion.
</div>
<h2>Alias Gets Form Explorer, ADSK Adds AI to Tools</h2>
Autodesk Alias will be powered by Form Explorer, an automative design generation tool. The enhancements will be easy to integrate across the segments and will aid in designing and manufacturing complex products.
ADSK has acquired NAVASTO, a company focused on the use of AI to accelerate design and engineering. NAVASTO brings wind tunnel simulation into Alias&#39; early creative design process. It enables designers to predict and optimize the drag coefficient over an automotive exterior and its aerodynamics. This reduces the likelihood of redesigns during engineering.
ADSK is integrating AI in creative tools &mdash; Arnold, Flame, Maya, and Wonder Studio &mdash; to fasten creative workflow.
ADSK&#39;s Wonder Studio will be made capable of anticipating character movement in spite of object obstruction and making natural poses with less noise and shaking.
Neutral Motion Control, Autodesk&#39;s latest prototype, will allow animators to direct action using limited keyframes and neural networks.
Autodesk also announced that it will now connect Autodesk Forma with Autodesk Docs to increase collaboration between platforms.
<h2>Autodesk Rides on Strong Portfolio</h2>
Autodesk shares have returned 9.5% in a month, outperforming the broader Zacks Computer and Technology sector&#39;s appreciation of 4.7%.
ADSK has outperformed the Zacks Computer &ndash; Software industry and its peers like Intuit (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intu#NASDAQ">INTU</a>), ANSYS (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anss#NASDAQ">ANSS</a>) and Verint Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrnt#NASDAQ">VRNT</a>).
Over the same time frame, shares of ANSYS have returned 3.3%, while Intuit and Verint have declined 3.7% and 11.6%, respectively. The industry has returned break-even YTD.
Autodesk&#39;s performance is gaining from new business growth, steady subscription renewal rates, and strong competitive performance. Higher demand for its cloud-based products, mobile solutions, and design suites is expected to drive the company&#39;s revenues over the long haul.
The rapid adoption of BIM 360 products and the success of the maintenance of the subscription program bode well for the growth of the company.
<h2>ADSK Guidance Positive</h2>
For fiscal 2025, ADSK expects revenues between $6.08 billion and $6.13 billion. In fiscal 2024, Autodesk generated total revenues of $5.5 billion.
For fiscal 2025, ADSK expects its non-GAAP earnings between $8.18 per share and $8.31 per share.
For the third quarter of fiscal 2025, Autodesk expects revenues between $1.555 billion and $1.57 billion. Non-GAAP earnings are anticipated between $2.08 per share and $2.14 per share.
<h2>Earnings Estimates Are Bright for Autodesk</h2>
The Zacks Consensus Estimate for ADSK&#39;s third-quarter fiscal 2025 earnings is pegged at $2.11 per share, up by a penny over the past 30 days, and indicates 1.93% year-over-year growth.
The consensus mark for fiscal 2025 earnings is pegged at $8.24 per share, unchanged in the past 30 days, and indicates 8.42% year-over-year growth.
Autodesk&#39;s earnings beat the Zacks Consensus Estimate in all the trailing four quarters, the average surprise being 5.94%.
<h2>Autodesk Shares &ndash; Is it the Right Time to Jump in?</h2>
ADSK shares are overvalued, as suggested by a Value Score of D.
In terms of the forward 12-month Price/Earnings (P/E) ratio, ADSK is trading at 45.76X, higher than the Zacks Computer &amp; Technology sector&#39;s 27.09X.
However, ADSK&#39;s growth prospects, driven by product portfolio enhancement capable of capitalizing on the rapid adoption of designing and manufacturing, justifies the premium valuation.
Autodesk currently has a Zacks Rank #2 (Buy), which implies that it is the right time for investors to accumulate ADSK stock.
<a href="https://www.zacks.com/stock/news/2352533/can-adsk-s-ai-powered-product-enhancements-push-the-stock-higher?cid=CS-BENZ-FT-analyst_blog|company_news_tech_sector-2352533">To read this article on Zacks.com click here.</a>

Earnings

Earnings Beats

Large Cap

Guidance

Small Cap

Markets

Analyst Ratings

Tech

Trading Ideas

ADSK

ANSS

INTU

VRNT

Can ADSK's AI-Powered Product Enhancements Push the Stock Higher?

Investors with a lot of money to spend have taken a bearish stance on Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PANW, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 23 uncommon options trades for Palo Alto Networks.
This isn't normal.
The overall sentiment of these big-money traders is split between 30% bullish and 47%, bearish.
Out of all of the special options we uncovered, 5 are puts, for a total amount of $168,183, and 18 are calls, for a total amount of $752,562.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $190.0 to $510.0 for Palo Alto Networks over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Palo Alto Networks's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Palo Alto Networks's whale activity within a strike price range from $190.0 to $510.0 in the last 30 days. 
<h3>Palo Alto Networks Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729193577_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$19.2</td>
<td>$18.65</td>
<td>$18.97</td>
<td>$370.00</td>
<td>$94.8K</td>
<td>1.7K</td>
<td>71</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$18.9</td>
<td>$18.75</td>
<td>$18.75</td>
<td>$400.00</td>
<td>$75.0K</td>
<td>2.4K</td>
<td>666</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$8.25</td>
<td>$8.25</td>
<td>$8.25</td>
<td>$370.00</td>
<td>$72.6K</td>
<td>2.1K</td>
<td>453</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$8.3</td>
<td>$8.2</td>
<td>$8.2</td>
<td>$370.00</td>
<td>$50.0K</td>
<td>2.1K</td>
<td>514</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$9.4</td>
<td>$9.3</td>
<td>$9.3</td>
<td>$370.00</td>
<td>$46.5K</td>
<td>2.1K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About Palo Alto Networks</h3>
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.
<h3>Current Position of Palo Alto Networks</h3>
<ul>
<li>With a volume of 965,884, the price of PANW is up 1.14% at $377.48. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 27 days.</li>
</ul>
<h3>Professional Analyst Ratings for Palo Alto Networks</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $416.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Exane BNP Paribas downgraded its rating to Outperform, setting a price target of $410. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Palo Alto Networks with a target price of $410. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on Palo Alto Networks with a target price of $421. 
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on Palo Alto Networks, maintaining a target price of $425. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Palo Alto Networks with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

PANW

Palo Alto Networks's Options: A Look at What the Big Money is Thinking

Investors with a lot of money to spend have taken a bearish stance on Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SPOT, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 11 uncommon options trades for Spotify Technology.
This isn't normal.
The overall sentiment of these big-money traders is split between 36% bullish and 63%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $153,180, and 7 are calls, for a total amount of $1,058,860.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $280.0 to $430.0 for Spotify Technology during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Spotify Technology stands at 382.7, with a total volume reaching 1,220.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Spotify Technology, situated within the strike price corridor from $280.0 to $430.0, throughout the last 30 days.
<h3>Spotify Technology Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729193572_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$11.45</td>
<td>$11.05</td>
<td>$11.1</td>
<td>$400.00</td>
<td>$388.5K</td>
<td style="text-align: right;">264</td>
<td style="text-align: right;">353</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$48.8</td>
<td>$48.8</td>
<td>$48.8</td>
<td>$430.00</td>
<td>$253.7K</td>
<td style="text-align: right;">86</td>
<td style="text-align: right;">52</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$49.8</td>
<td>$48.8</td>
<td>$48.8</td>
<td>$430.00</td>
<td>$146.4K</td>
<td style="text-align: right;">86</td>
<td style="text-align: right;">82</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$2.41</td>
<td>$1.59</td>
<td>$2.1</td>
<td>$377.50</td>
<td>$107.5K</td>
<td style="text-align: right;">533</td>
<td style="text-align: right;">550</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$99.8</td>
<td>$98.0</td>
<td>$98.0</td>
<td>$280.00</td>
<td>$98.0K</td>
<td style="text-align: right;">435</td>
<td style="text-align: right;">10</td>
</tr>
</tbody>
</table>

<h3>About Spotify Technology</h3>
Spotify, headquartered in Stockholm, Sweden, is one of the world's largest music streaming service providers, with 602 million monthly active users at the end of 2023. The firm monetizes its users through a paid subscription model, referred to as its premium service, and an ad-based model, referred to as its ad-supported service. Revenue from premium and ad-supported services represented 86% and 14% of Spotify's 2023 total revenue, respectively.
After a thorough review of the options trading surrounding Spotify Technology, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Spotify Technology</h3>
<ul>
<li>Currently trading with a volume of 748,814, the SPOT's price is down by -0.43%, now at $370.1. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 26 days.</li>
</ul>
<h3>What The Experts Say On Spotify Technology</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $423.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Neutral with a new price target of $340. 
&#x2A; Maintaining their stance, an analyst from Keybanc continues to hold a Overweight rating for Spotify Technology, targeting a price of $490. 
&#x2A; An analyst from Rosenblatt persists with their Buy rating on Spotify Technology, maintaining a target price of $438. 
&#x2A; Consistent in their evaluation, an analyst from Pivotal Research keeps a Buy rating on Spotify Technology with a target price of $510. 
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Neutral, setting a price target of $340. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Spotify Technology options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

SPOT

This Is What Whales Are Betting On Spotify Technology

Financial giants have made a conspicuous bearish move on Reddit. Our analysis of options history for Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) revealed 20 unusual trades.
Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 10 were puts, with a value of $1,268,829, and 10 were calls, valued at $514,666.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $42.5 to $81.0 for Reddit during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Reddit's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Reddit's whale activity within a strike price range from $42.5 to $81.0 in the last 30 days. 
<h3>Reddit Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729193567_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/01/24</td>
<td>$3.6</td>
<td>$3.3</td>
<td>$3.55</td>
<td>$75.00</td>
<td>$359.5K</td>
<td>322</td>
<td>2.3K</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$4.45</td>
<td>$4.25</td>
<td>$4.45</td>
<td>$75.00</td>
<td>$267.0K</td>
<td>185</td>
<td>616</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/01/24</td>
<td>$3.2</td>
<td>$3.05</td>
<td>$3.2</td>
<td>$75.00</td>
<td>$196.2K</td>
<td>322</td>
<td>616</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/01/24</td>
<td>$3.95</td>
<td>$3.55</td>
<td>$3.9</td>
<td>$75.00</td>
<td>$122.8K</td>
<td>322</td>
<td>3.1K</td>
</tr>
<tr>
<td>RDDT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/25/24</td>
<td>$3.4</td>
<td>$3.35</td>
<td>$3.4</td>
<td>$75.00</td>
<td>$104.7K</td>
<td>2.7K</td>
<td>667</td>
</tr>
</tbody>
</table>

<h3>About Reddit</h3>
Reddit Inc is engaged in providing internet content. The company provides online services that include gaming, sports, business, crypto, television and others.
After a thorough review of the options trading surrounding Reddit, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Reddit</h3>
<ul>
<li>Trading volume stands at 2,121,397, with RDDT's price down by -0.31%, positioned at $77.02.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 12 days.</li>
</ul>
<h3>What Analysts Are Saying About Reddit</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $77.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Raymond James has decided to maintain their Strong Buy rating on Reddit, which currently sits at a price target of $80. 
&#x2A; An analyst from Jefferies downgraded its action to Buy with a price target of $90. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Neutral rating on Reddit, which currently sits at a price target of $68. 
&#x2A; In a cautious move, an analyst from B. Riley Securities downgraded its rating to Buy, setting a price target of $75. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $75. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Reddit options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

RDDT

Reddit Unusual Options Activity

Hartford Finl Servs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>) has outperformed the market over the past 5 years by 1.92% on an annualized basis producing an average annual return of 16.22%. Currently, Hartford Finl Servs Gr has a market capitalization of $35.73 billion. 
Buying $100 In HIG: If an investor had bought $100 of HIG stock 5 years ago, it would be worth $204.05 today based on a price of $121.94 for HIG at the time of writing.
<h3>Hartford Finl Servs Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729193566_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Hartford Finl Servs Gr 5 Years Ago Would Be Worth Today

Air Products &amp; Chemicals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) has outperformed the market over the past 20 years by 1.26% on an annualized basis producing an average annual return of 9.88%. Currently, Air Products &amp; Chemicals has a market capitalization of $72.63 billion. 
Buying $100 In APD: If an investor had bought $100 of APD stock 20 years ago, it would be worth $670.90 today based on a price of $326.70 for APD at the time of writing.
<h3>Air Products &amp; Chemicals's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729193561_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Air Products & Chemicals Stock In The Last 20 Years

As cannabis legalization continues to expand across the U.S., its use among cancer patients has also increased significantly, particularly for managing symptoms like nausea, pain, anxiety and insomnia.
A recent <a href="https://www.cancer.gov/news-events/cancer-currents-blog/2024/medical-cannabis-oncologists-patients-communication">blog entry</a> from Carmen Phillips at the National Cancer Institute (NCI), a part of the <a href="https://www.benzinga.com/markets/cannabis/24/10/41322400/curious-about-cannabis-edibles-fed-health-agency-funds-project-to-study-use-among-young-adults">National Institute of Health</a> (NIH), underscores the growing demand for more robust scientific research on cannabis, especially as more cancer patients turn to it as a form of relief.
Oncologists call attention to the urgent need to reschedule cannabis to facilitate further research and fill &#8220;the Cannabis-and-Cancer Information Gap&#8221;.
<h3 class="wp-block-heading">Rising Cannabis Use Among Cancer Patients</h3>
Recent studies estimate that between 20% to 40% of cancer patients use cannabis or cannabinoids to manage side effects from both the disease and its treatment. With 38 states having legalized medical marijuana, patients are finding it easier than ever to access products.
Dr. Richard T. Lee, who heads the Cherng Family Center for Integrative Oncology at City of Hope in California, addressed the rising interest. &#8220;Patients are highly interested in cannabis to help them deal with cancer's physical and mental fallout.&#8221;
As additional states legalize cannabis for medical use, this trend is expected to grow, placing more pressure on <a href="https://www.benzinga.com/markets/cannabis/24/09/40900626/legal-medical-cannabis-could-save-us-healthcare-29b-annually-new-study-finds">healthcare</a> providers to understand the nuances of cannabis use.
While many <a href="https://www.benzinga.com/topic/oncology">oncologists</a> acknowledge that their patients are using cannabis, the lack of clinical evidence leaves them ill-prepared to offer concrete guidance. In a recent survey published by the NCI, nearly 40% of oncologists said they were comfortable discussing cannabis with their patients, but only 13% felt knowledgeable enough to provide accurate advice.
Similarly, other studies show that only 20% of patients using cannabis inform their oncologists.
Read Also: <a href="https://www.benzinga.com/general/biotech/24/01/36512822/cannabis-significantly-improves-symptoms-for-most-cancer-survivors-confirms-new-study">Cannabis Significantly Improves Symptoms For Most Cancer Survivors, Confirms New Study</a>
<h3 class="wp-block-heading">Rescheduling Cannabis To Advance Research</h3>
The NCI&#8217;s blog post highlights the pressing need for more research, particularly as cannabis remains classified as a Schedule I drug &#8211; the same category as heroin. This <a href="https://www.benzinga.com/markets/cannabis/24/04/38531432/deas-move-to-reclassify-cannabis-seen-as-significant-but-fails-to-resolve-state-federal-conflict">federal classification</a> restricts large-scale studies, limiting the ability of researchers to fully explore cannabis&#8217;s potential therapeutic benefits and risks for cancer patients.
<a href="https://www.benzinga.com/topic/cannabis-rescheduling">Rescheduling cannabis </a>to a lower classification could open doors for rigorous scientific studies that would offer clearer guidelines for healthcare providers.
&#8220;We absolutely … don't have a good handle on safety,&#8221; said Gary Ellison, Ph.D., M.P.H., of the NCI. He explained that the federal restrictions on cannabis make it difficult to conduct comprehensive research, creating gaps in knowledge that leave both patients and providers in the dark. &#8220;The potential harms, particularly with immunotherapy, are not fully understood. Without rescheduling, we can't investigate this properly.&#8221; 
One of the primary concerns among oncologists is how cannabis might interact with standard cancer treatments, particularly&nbsp;immunotherapy, which plays a critical role in treating certain types of cancer. 
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/10/41216874/cannabinoids-show-promising-anti-cancer-potential-yet-mechanisms-remain-unclear-new-study">Cannabinoids Show Promising Anti-Cancer Potential Yet Mechanisms Remain Unclear, New Study</a></li>
</ul>
Cover: AI generated image

Cannabis

Government

Regulations

Health Care

As Cannabis Use Grows Among Cancer Patients, Federal Agency Highlights Need For Rescheduling

During a recent <a href="https://www.youtube.com/live/DaM8VQgPisg?si=a4f1TLHMIXzfclyk&amp;t=1191">speech</a> at the Philadelphia City Committee dinner, President Joe Biden was unrestrained in his shots at his predecessor, Donald Trump. Biden fiercely ridiculed Trump for having bankrupted a casino, a move that particularly baffled him. &#8220;How is that possible? I thought the house always won,&#8221; Biden quipped, drawing laughs from the audience.
Don't Miss:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
</ul>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Biden: &quot;Trump likes to call himself pro-business. We all know Trump is a failed businessman &#8230; including bankrupting a casino in Atlantic City, which is pretty hard to do. How is that possible? I thought the house always won. Trump wasn&#39;t only a loser in 2020. He&#39;s a loser in… <a href="https://t.co/I8UxtQoY3H">pic.twitter.com/I8UxtQoY3H</a>
&mdash; Aaron Rupar (@atrupar) <a href="https://twitter.com/atrupar/status/1846333961561104709?ref_src=twsrc%5Etfw">October 15, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Biden addressed Trump&#8217;s business record as part of a broader critique of Trump&#8217;s presidency and economic policies. He pointed out that Trump, who inherited millions, still <a href="https://www.benzinga.com/general/24/02/37264271/warren-buffett-exposed-the-reason-for-trumps-failed-business-ventures-decades-before-the-fraud-case">managed to run several businesses into the ground</a>, including a casino in Atlantic City. &#8220;He inherited 100 million dollars and he went bankrupt how many times? I can&#8217;t keep track,&#8221; the President said.
Trending: This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's an opportunity to invest at $1,000 for only $0.50/share today.</a>
Biden said that Trump&#8217;s claim to be &#8216;pro-business&#8217; doesn&#8217;t match up with his record of going bankrupt multiple times and having a messy presidency. Biden compared Trump&#8217;s failures with the success of his own administration, saying, &#8220;On our watch, businesses of all sizes are surging [and there&#8217;s] a record number of small business applications." Trump's actions didn't help regular people.
Biden also mentioned the larger economic gains made possible by his administration, such as the <a href="https://www.benzinga.com/economics/24/10/41207486/the-hiring-situation">creation of millions of new jobs</a>, salary increases, the decline in violent crime and the expansion of health care access.&nbsp;
He used these accomplishments as evidence that, in comparison to Trump&#8217;s presidency, his administration has been more successful in raising the standard of living for working Americans.
Trending: Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a>
"Trump wasn't just a loser in 2020," Biden said, "he's a loser in everything he does." The crowd responded with cheers as Biden painted Trump as a man out of touch with the needs of regular Americans and someone who has repeatedly failed, both in business and in public service.
Still, no matter what the President says, many <a href="https://www.benzinga.com/personal-finance/24/04/38112723/suze-orman-doesnt-believe-people-are-doing-ok-despite-being-told-the-economy-is-strong-in-my-opi">people still feel the pinch</a>, struggling to make ends meet with <a href="https://www.benzinga.com/economics/macro-economic-events/24/05/39001824/janet-yellen-acknowledges-rising-cost-of-living-is-a-problem-to-a-lot-of-people-a">rising living costs</a> and uncertainty about their financial future. Many families are struggling to afford necessities like groceries, rent and health care as prices keep increasing.
Even though there are more jobs and higher wages, not everyone sees the benefits. Many people still have to work more than one job just to get by. The <a href="https://www.benzinga.com/general/24/02/36941891/the-wealth-gap-widens-the-5-richest-billionaires-got-2x-richer-as-5-billion-people-continue-to-get-p">difference between rich and poor is still large</a> and many Americans feel like they are being left out, even with all the talk about the economy getting better. Because of this, it&#8217;s hard for some people to believe the positive picture the government is showing since they are still struggling with money every day.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a></li>
</ul>

Startups

In A Brutal Takedown, Joe Biden Mocks Trump Bankrupting A Casino – 'How Is That Possible? I Thought The House Always Won'

Bank of America released a bullish note on gold Thursday, just as the precious metal <a href="https://www.benzinga.com/topic/gold">reached new record highs</a> at $2,696 per ounce (oz).
Gold remains &#8220;the ultimate perceived safe haven asset&#8221; in today's macroeconomic environment, according to Bank of America&#8217;s commodity analyst Michael Widmer, amid rising concerns over U.S. fiscal policies and their potential <a href="https://www.benzinga.com/news/treasuries">impact on Treasury yields.</a>
<h3 class="wp-block-heading">Gold Trends Higher As Fed Shifts Policy</h3>
Despite nominal U.S. Treasury yields trending upward, gold prices, as tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), have been climbing in recent weeks, supported by various factors.
Widmer explained that a key driver behind this surge is the rising inflation expectations paired with the Federal Reserve's policy shifts.
Rate cuts triggered a surge in inflation expectations, which in turn kept downward pressure on real yields, increasing gold&#8217;s appeal as an inflation hedge.
&#8220;Accompanying the first Fed&#8217;s 50bp rate cut, inflation expectations have risen, meaning that 10-year real yields, usually the most significant gold price driver, kept declining through September,&#8221; Widmer said.
<h3 class="wp-block-heading">Gold Hits All-Time Highs On Oct. 17</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="464" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17145515/image-156-1024x464.png" alt="" class="wp-image-601508" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17145515/image-156-1024x464.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17145515/image-156-300x136.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17145515/image-156-768x348.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17145515/image-156-1536x696.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17145515/image-156.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Chart: <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent101724&amp;t=be2bearmibe3na1">Benzinga Pro</a></figcaption></figure>
<h3 class="wp-block-heading">U.S. Fiscal Policy Boosts Bullish Gold Outlook</h3>
A key factor bolstering Bank of America's bullish stance on gold is the U.S.&#8217;s fiscal trajectory. 
Rising interest rates have significantly increased the federal government&#8217;s debt servicing costs, triggering concerns about fiscal sustainability. According to government projections, the national debt is projected to reach a new record high as a share of the U.S. economy within the next three years.
Widmer highlighted that &#8220;whoever wins the 2024 presidential election will face an unprecedented fiscal situation upon taking office. Neither Kamala Harris nor Donald Trump seems to prioritize fiscal consolidation.&#8221;
The CRFB report details that Vice President Harris's proposed policies could increase the national debt by $3.5 trillion through 2035, while former President Trump's platform might raise it by as much as $7.5 trillion. "
The large and growing national debt threatens to &#8220;to slow economic growth, boost interest rates and payments, weaken national security, constrain policy choices, and&nbsp;raise&nbsp;the risk of an eventual fiscal crisis.&#8221;&nbsp;
<h3 class="wp-block-heading">Global Trends Also Favor Gold</h3>
According to Widmer, fiscal expansion policies are gaining traction across advanced economies, contributing to gold&#8217;s global appeal. The International Monetary Fund (IMF) estimates that new fiscal spending related to climate adaptation, demographic shifts, and rising defense costs could amount to 7-8% of global GDP annually by 2030.
This massive spending will likely force governments to issue more debt, and as volatility in the bond markets rises, gold will emerge as a refuge for investors, Widmer explained. 
Central banks are also anticipated to increase their gold holdings as part of currency reserve diversification. The share of global central bank reserves held in gold has climbed to 10%, up from just 3% a decade ago.
<h3 class="wp-block-heading">Outlook for Gold: $3,000/oz By 2025</h3>
Bank of America sees gold reaching the $3,000/oz mark by the first half of 2025. The combination of macroeconomic uncertainty, rising debt levels, and central bank buying makes gold the &#8220;last safe haven asset standing.&#8221;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41386234/strong-september-retail-sales-put-feds-next-move-in-doubt-interest-rate-cuts-are-">Strong September Retail Sales Put Fed&#8217;s Next Move In Doubt: Interest Rate Cuts Are &#8216;Not A Slam Dunk&#8217;</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Commodities

Econ #s

Federal Reserve

ETFs

Gold Could Reach $3,000 By 2025, Bank Of America Analyst Says: 'Ultimate Perceived Safe Haven'

Source: <a href="https://www.streetwisereports.com/article/2024/10/15/co-says-geoprobe-drilling-found-consistent-lithium-boron-concentrations.html?utm_medium=feed">Streetwise Reports 10/15/2024</a>
Canter Resources Corp. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/cnrcf#OTC">CNRCF</a>) announced promising brine assay results from Phase II geoprobe drilling at its Columbus Lithium-Boron Project near Tonopah, Nevada.
The company said the results show &quot;consistent lithium and boron concentrations identified across an expanded widespread area&quot; with initial multi-element analysis strengthening the project&#39;s &quot;potential for significant lithium and boron brine development.&quot;
&quot;We completed two phases of shallow drilling for a total of 20 drill holes . . . proving the basin&#39;s ability to generate mineralized brines from the surrounding source rocks and guiding our deeper discovery drilling&quot; Chief Executive Officer Joness Lang told Streetwise Reports.
Canter said solid sediment assays expected mid-Q4 will contribute to an updated 3D model of the basin and lead the way for Phase III exploration plans.
According to the company, the phased shallow drilling program shows that the Columbus Basin can generate the same lithium-boron mix in brines as Ioneer&#39;s (CA$300 million market cap) nearby Rhyolite Ridge sediment deposit. Rhyolite Ridge shares volcanic source rocks with Columbus.
&quot;Rhyolite Ridge is at feasibility stage, and we are building the foundation for a major discovery at Columbus, but these shallow results certainly support our vision for value creation&quot; Lang said. &quot;The lithium results at this depth are as expected and fit the widely adopted basin deposit model (Clayton Valley), while the boron results have exceeded expectations and point to the significant co-product multi-commodity potential at Columbus.&quot;
<h2>Lithium on its Way Up?</h2>
The lithium sector has been on a roller coaster this year. It peaked at a high of more than US$79,637 per ton in 2022, but expected sales of electric vehicles (EVs) did not materialize, and prices hit their lowest point in three years in 2024.
But in an article for Reuters, Andy Home wrote that the slowdown could easily be reversed.
&quot;One critical facilitator will be the build-out of EV charging infrastructure, a sector which has attracted far less investment than battery manufacturing&quot; he wrote. &quot;Car buyers in Europe and the United States are choosing hybrids because of range anxiety, and they will continue to do so until they see more charging points. The second key factor is price.&quot;
<blockquote class="callOut left">Jeff Clark, in The Gold Advisor, pointed out the strategic importance of the company&#39;s drilling efforts. &quot;There is a lot of activity ahead for this young company on a project that shows the potential to match what its neighbors have&quot; he wrote.</blockquote>
However, &quot;the seeds of the next lithium upswing are already being sown in the current low-price environment&quot; Home wrote.
Clearly, one major mining company is taking that bet. Rio Tinto has agreed to a US$6.7 billion takeover of Arcadium Lithium, offering US$5.85 per share in cash for the company a 90% premium to the stock&#39;s closing price at the end of last week, David Winning and Julie Steinberg wrote for Reuters on Wednesday.
&quot;Rio Tinto expects demand for lithium to rise in the decade ahead because of the metal&#39;s importance to EVs and in large batteries that store electricity that can be released into the grid when consumption surges&quot; the authors noted. &quot;The U.S. has designated lithium as a critical mineral.&quot;
Boron is also essential to the energy transition. The Business Research Co. reports the global market has grown &quot;exponentially in recent years&quot; and forecasts it will reach US$7.99 billion this year, up from US$6.57 billion in 2023, reflecting a 21.7% CAGR. Rapid growth is expected to continue in the sector through 2028, at which time the market is projected to reach US$12.68 billion.
<h2>&#39;Very Encouraging Signs&#39;</h2>
In the new Phase II results, Canter said infill drill hole CB24-023G returned 871 milligrams per liter (mg/L) boron and the highest dissolved boron concentration from Canter&#39;s drilling to date, 820 mg/L. This provides further &quot;evidence of significant boron concentrations with increasing grades at depth&quot; the company said in a release.
The Phase II lithium results also continued to demonstrate the consistent, widespread anomalous lithium mineralization in brines. Shallow drilling to-date has returned several brine samples greater than 40 mg/L and a peak value of 76.4 mg/L in the upper 30 meters, Canter said.
Data from Albemarle&#39;s Silver Peak lithium brine operation in Clayton Valley show lithium concentrations increase with depth, and Canter&#39;s lithium concentrations in the upper 100 feet (~30 meters) are &quot;very comparable, with higher peak values than historically observed in Clayton Valley from the upper 100 meters&quot; Lang said.
The company believes there should be &quot;higher-grade lithium in the reservoirs and structural traps in this basin as we drill deeper&quot; he noted. &quot;That would fit the basin deposit model methodology used throughout the western U.S.A.&quot; he added.
These are &quot;all really encouraging signs from very cost-effective shallow drilling that&#39;s all intended to help vector us towards the best places to take our discovery shots when drilling deeper in subsequent campaigns&quot; Lang said. &quot;So, we&#39;re really encouraged with what we&#39;ve seen.&quot;
<h2>Elements Vital to Energy Transition</h2>
Lithium is a critical metal vital in the energy transition for its use in batteries for EVs and other applications. It also is used in electronics, medicine and other industries.
According to a report by Grand View Research, market size for the metal was estimated at US$31.75 billion last year and is projected to grow at a compound annual growth rate (CAGR) of 17.7% from this year through 2030.
&quot;The automotive application segment is expected to witness substantial growth, driven by stringent regulations imposed by government bodies on ICE automakers to reduce carbon dioxide emissions from vehicles&quot; researchers at Grand View said. &quot;This has shifted the interest of automakers toward producing EVs, which is anticipated to benefit the demand for lithium and related products.&quot;
EVs and battery storage primarily will fuel future growth of the lithium market, Marin Katusa of Katusa Research wrote recently. He pointed out that all major electric vehicle batteries require lithium, about 1.55 pounds per kilowatt hour of battery capacity, on average.
&quot;I think the data speaks for itself that there&#39;s more growth and opportunity on the horizon&quot; Katusa wrote.
Boron/borates are used in applications in agriculture, metallurgy, nuclear energy, and advanced materials, Mordor Intelligence noted. The increasing use of fiberglass in various end-user industries is also boosting demand for the element.
According to the U.S. Geological Survey, borates are also used in abrasives, cleaning products, insecticides, insulation, ceramics, and semiconductors.
&quot;Growing demand for electronic products and increasing penetration of fiberglass in markets conventionally held by concrete and steel are expected to drive boron market growth&quot; Grand View Research noted. &quot;Fiberglass penetration in turbine blades in wind power generation is also expected to have positive influence on boron market development. An increase in construction spending, leading to fiberglass demand for a communal structure such as bridges and roads is expected to come up as a new opportunity for the global market. The scarcity of boron, very concentrated reserves, and multifaceted manufacturing process may be a challenge for participants in the global market.&quot;
<h2>&#39;A Great Basin of Lithium and Boron&#39;</h2>
Chen Lin wrote in his newsletter What Is Chen Buying? What Is Chen Selling? that Canter &quot;is looking good [and the Columbus project] hosts a great basin of lithium and boron though the market is not looking at it.&quot;
Jeff Clark, in The Gold Advisor, pointed out the strategic importance of the company&#39;s drilling efforts.
&quot;There is a lot of activity ahead for this young company on a project that shows the potential to match what its neighbors have&quot; he wrote.
<h2>Ownership and Share Structure</h2>
According to the company, managers and insiders own about 9.6% of Canter Resources, and strategic investors (including the founding group and Michael Gentile &amp; Advisors) own about 12%.
The investors with the largest stake are all insiders. They are CEO and Director Joness Lang with 3.38%, Director and Strategic Adviser Warwick Smith with 2.14%, Director and Technical Adviser Kenneth Cunningham with 1.95%, Chief Financial Officer Alnesh Mohan with 0.97%, and Director and Technical Adviser Eric Saderholm with 0.58%, and Gentile, who owns about 4% personally.
Four institutions or funds, including Euro Pacific Asset Management, collectively hold 3%. Retail investors own the remaining.
The Canadian explorer has 51.29 million outstanding shares, 46.41 million free float traded shares with a CA$4.11 million market cap.
Over the past 52 weeks, Canter has traded between CA$0.07 and CA$0.99 per share.
Important Disclosures:
<ol>
<li>As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Canter Resources Corp.</li>
<li>Steve Sobek wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.</li>
<li>This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports&#39; terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.</li>
</ol>

Penny Stocks

Offerings

CNRCF

Co. Says Geoprobe Drilling Found 'Consistent' Lithium, Boron Concentrations

<a href="https://www.fda.gov/media/182763/download" title="https://www.fda.gov/media/182763/download">https://www.fda.gov/media/182763/download</a>

HUMA

FDA Form 483 Highlights Key Compliance Issues at Humacyte Global, Including Microbial Testing Gaps, Delayed OOS Investigations, And Deficiencies in Quality Management; Aims To Address Safety And Quality Concerns Under Federal Food, Drug, And Cosmetic Act

RKLB

Biden Administration To Ease Export Controls For U.S. Space Companies Shipping Satellite And Spacecraft-Related Items To Allies; Easing Restrictions On Remote Sensing Spacecraft And Space-Based Logistics Assembly For Shipments To Australia, Canada, And The UK, Sources Say

WIIM

PSTG

Pure Storage shares are trading higher after Guggenheim raised its price target on the stock from $72 to $93.

Truist Financial shares are trading lower. The company reported Q3 financial results.

The Medical Services sector is experiencing significant evolution driven by innovation and digital applications. Growing demand for remote treatment has led to a tremendous upsurge in digital healthcare options over the past few years. Demand for digital healthcare treatment continues to grow in the form of telemedicine-focused online medical and AI-powered technology services backed by the adoption of data and analytics.
According to a recent Mordor Intelligence report, the global healthcare analytics market is expected to surpass $130 billion by 2029, witnessing a CAGR of 22.9% from 2024 to 2029. Primary stakeholders &mdash; payers, healthcare professionals and patients &mdash; will benefit from all-new insights, services and levels of experience that next-generation healthcare-related data and analytical capabilities provide. Stocks like Elevance Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/elv#NYSE">ELV</a>), Doximity (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/docs#NYSE">DOCS</a>)&nbsp;and HealthEquity (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hqy#NASDAQ">HQY</a>) are expected to gain the most from the rapidly transforming healthcare services landscape.
However, in the post-pandemic era, manual workforce shortage within healthcare has become a worldwide problem, weighing heavily on healthcare infrastructure. According to an August 2024 report by Mercer, there will be a deficit of more than 100,000 healthcare workers in the United States by 2028. Within this, nursing assistants will have the biggest projected deficit compared to other healthcare occupations, signaling the need to improve talent attraction and retention strategies for this segment. By 2028, Mercer expects a projected deficit of over 73,000 nursing assistants nationwide. This has led to increased labor cost and health expenses.
Industry Description
The Zacks Medical Services industry comprises third-party service providers and caregivers appointed by core healthcare companies for economies of scale. The industry includes pharmacy benefit managers, contract research organizations, wireless MedTech companies, third-party testing labs, surgical facility providers and healthcare workforce solution providers, among others. Over the years, this industry has strategically moved from volume- to value-based care. This changing pattern of care calls for advanced facilities, thus increasing the need to appoint specialized external service providers. With the growing importance of effective healthcare management, the medical service industry has become an integral part of the modern healthcare system.
3 Trends Shaping the Future of the Medical Services Industry
Digital Revolution: With an increase in the adoption of digital platforms within the medical device space, remote monitoring, robotic surgeries, big-data analytics, 3D printing and electronic health records are gaining prominence in the United States. A 2024 digital health market report by Statista suggests that this market will witness a 9.2% CAGR from 2024 to 2028, resulting in a projected market volume of $275 billion by 2028. Other reports suggest that companies that adopted artificial intelligence technologies witnessed a 50% reduction in treatment costs and experienced more than 50% improvement in patient outcomes.
Revival in Nursing Care Market: With rising cognizance about the benefits of specialized medical caregiving, the need for healthcare workforce/staffing service providers has increased significantly. Despite challenges like workforce shortages and increased costs, the market is rebounding post-pandemic. Factors such as rising chronic diseases, healthcare awareness and strategic initiatives by companies and governments drive this growth. For example, the demand for nurses has increased manifold, driven by the rising incidence of chronic disorders in the United States, and is expected to be high in the days ahead. Per a Research and Markets report, the global healthcare staffing market size is expected to reach $62.8 billion by 2030, registering a CAGR of 6.9% from 2023 to 2030.
Staffing Shortage: Despite the end of the healthcare emergency (WHO declared the end of COVID-19 as a global health emergency on May 5), the trauma of the past few years&#39; uncertainty and commotion has forced frontline workers like doctors and medical staff to leave the field. Added to this, a drastic increase in the aging population in recent times (about 10,000 individuals aged 59-77 are joining Medicare plans daily) has made the healthcare staffing shortage more pronounced. In the article &quot;A Public Health Crisis: Staffing Shortages in Health Care&quot; published in Favorite Healthcare Staffing, WHO predicts a shortfall of 15 million healthcare workers worldwide in 2030. Needless to say, this supply shortage has led to a significant rise in healthcare wages. Going by a HR for Health report,&nbsp; increased labor costs and staffing challenges have led to a rise in hospital expenses. Hospitals have experienced a 15.6% increase in labor expenses per adjusted discharge compared to pre-pandemic levels.
Zacks Industry Rank Indicates Gloomy Prospects
The Zacks Medical Services industry falls within the broader Zacks Medical sector. It carries a Zacks Industry Rank #170, which places it in the bottom 32% of more than 250 Zacks industries.
The group&#39;s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates dull near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperforms the bottom 50% by a factor of more than 2 to 1.
We will present a few stocks that have the potential to outperform the market based on a strong earnings outlook. But it&#39;s worth taking a look at the industry&#39;s shareholder returns and current valuation first.
Industry Underperforms Sector and S&amp;P 500
The Medical Services Industry has underperformed its sector and the S&amp;P 500 over the past year. The stocks in this industry have collectively gained 8.9% during the said time frame compared with the Medical sector&#39;s 12.5% rise and the S&amp;P 500 composite&#39;s surge of 34.3%.
<h3>One-Year Price Performance</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/chart 1_171024.jpg" style="border-style:solid; border-width:1px; height:200px; width:620px" />
Industry&#39;s Current Valuation
On the basis of forward 12-month price-to-earnings (P/E), which is commonly used for valuing medical stocks, the industry is currently trading at 15.01X compared with the S&amp;P 500&#39;s 22.09X and the sector&#39;s 22.75X.
Over the last five years, the industry has traded as high as 19.80X, as low as 11.83X, and at the median of 15.52X, as the charts below show.
<h3>Price-to-Earnings Forward Twelve Months (F12M)</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/chart 2_171024.jpg" style="border-style:solid; border-width:1px; height:157px; width:620px" />
<h3>Price-to-Earnings Forward Twelve Months (F12M)</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/chart 3_171024.jpg" style="border-style:solid; border-width:1px; height:157px; width:620px" />
3 Stocks to Buy Right Now
Below, we present three stocks from the Medical Services industry that have been witnessing positive earnings estimate revisions and carry a Zacks Rank #1 (Strong Buy) or #2 (Buy) at present.
Elevance Health: Based in Indianapolis, IN, Elevance Health (previously named Anthem) is one of the largest publicly traded health insurers in the United States in terms of membership. ELV&#39;s revenue growth, fueled by premium rate increases and rising memberships in commercial business, contributes to its positive trajectory. Strategic acquisitions and partnerships have fortified its business portfolio. A robust Medicare Advantage segment, combined with successful contract acquisitions, is poised to drive future memberships.
Elevance Health&#39;s 2024 earnings growth rate is pegged at 12.4%. The Zacks Consensus Estimate for ELV&#39;s 2024 revenues indicates a year-over-year rise of 1.5%. The stock sports a Zacks Rank #1 currently.
<h3>Price and Consensus: ELV</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/elv_171024.jpg" style="border-style:solid; border-width:1px; height:160px; width:620px" />
Doximity: It is a digital platform for U.S. medical professionals. The company&#39;s network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules and conduct virtual patient visits.
This Zacks Rank #1 stock&#39;s fiscal 2025 expected earnings growth rate is pegged at 10.5%. The Zacks Consensus Estimate for DOCS&#39; fiscal 2025 revenues indicates a year-over-year rise of 9.4%.
<h3>Price and Consensus: DOCS</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/docs_171024.jpg" style="border-style:solid; border-width:1px; height:160px; width:620px" />
HealthEquity: Draper, UT-headquartered HealthEquity provides integrated solutions for healthcare account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity&#39;s sustained strength in Health Savings Accounts (HSAs) looks promising and is expected to enable it to maintain a leadership position in the HSA industry.
HQY&#39;s fiscal 2025 expected earnings growth rate is pegged at 37.3%. The Zacks Consensus Estimate for HealthEquity&#39;s fiscal 2025 revenues indicates a year-over-year rise of 18.2%. The stock carries a Zacks Rank #2 at present.
<h3>Price and Consensus: HQY</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/hqy_171024.jpg" style="border-style:solid; border-width:1px; height:160px; width:620px" />
<a href="https://www.zacks.com/commentary/2352203/3-medical-services-stocks-to-buy-to-navigate-industry-challenges?cid=CS-BENZ-FT-industry_outlook-2352203">To read this article on Zacks.com click here.</a>

Mid Cap

Contracts

General

DOCS

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

3 Medical Services Stocks to Buy to Navigate Industry Challenges

Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) shares are trading narrowly higher Thursday. Multiple analysts raised price targets ahead of earnings in two weeks. Here&#8217;s what <a href="https://www.benzinga.com/analyst-stock-ratings">you need to know</a>.
What To Know: Mizuho analyst James Lee maintained Meta with an Outperform rating and raised the price target from&nbsp;$600&nbsp;to&nbsp;$650 as he anticipates a beat-and-raise quarter from the tech giant later this month.
The Mizuho analyst noted that a series of ad agency checks shows that ad spending is ahead of consensus estimates and at the high-end of Meta&#8217;s guidance for 20% growth year-over-year. Lee believes the strength in ad spending is being driven by political advertising.
&#8220;Although the stock is a crowded trade into the print, we believe it is the only big tech internet name that could beat and raise with substantial optionality in messaging and Gen-AI for creative,&#8221; the analyst said.
See Also: <a href="https://www.benzinga.com/news/24/10/41388451/metas-ai-open-source-claims-draw-criticism-osi-pushes-for-transparency">Meta&#8217;s AI Open-Source Claims Draw Criticism, OSI Pushes For Transparency</a>
TD Cowen analyst John Blackledge also released a positive update on Meta on Thursday. The analyst maintained Meta with a <a href="https://www.benzinga.com/analyst-stock-ratings">Buy rating</a> and raised the price target from&nbsp;$600&nbsp;to&nbsp;$675 ahead of earnings. 
Meta is scheduled to report <a href="https://www.benzinga.com/pressreleases/24/10/n41128762/meta-to-announce-third-quarter-2024-results">third-quarter financial results</a> after the market close on Oct. 30. Analysts expect the company to report earnings of $5.23 per share and revenue of $40.238 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Last quarter, Meta <a href="https://www.benzinga.com/news/earnings/23/07/33402682/meta-platforms-q2-earnings-highlights-revenue-and-eps-beat-guidance-update-lower-costs-compelling-a">beat analyst estimates</a> as revenue jumped&nbsp;11% year-over-year and daily actives climbed 7%. The company noted at the time that ads delivered were up 34% year-over-year, while the average price per ad was down 16%.
&#8220;We had a good quarter. We continue to see strong engagement across our apps and we have the most exciting roadmap I&#8217;ve seen in a while with Llama 2, Threads, Reels, new AI products in the pipeline, and the launch of Quest 3 this fall,&#8221; CEO Mark Zuckerberg said in the second-quarter earnings release. 
Meta has exceeded analyst estimates on the top and bottom lines in six consecutive quarters, according to <a href="http://pro.benzinga.com">Benzinga data</a>. 
META Price Action: Meta shares were up 0.11% at $577.44 at the time of publication. Meta shares are up approximately 63% year-to-date, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Price Target

Movers

Analysts Lift Price Targets On Meta Platforms Stock Ahead Of Q3 Earnings: Here's Why

NRG Energy shares are trading lower after the company announced an upsized senior notes offering priced at $1.875 billion due 2033 and 2034.

The Israeli military confirmed on Thursday <a href="https://www.benzinga.com/markets/asia/24/10/41385179/hamas-chief-oct-7-mastermind-yahya-sinwar-possibly-dead-idf-conducts-dna-tests-after-gaza-clash">the death of Yahya Sinwar</a>, the top leader of Hamas, with one word: &#8220;Eliminated.&#8221; 
What Happened: Israel Defense Forces killed Sinwar — Israel's most wanted target since the war with Hamas began on Oct. 7 — in a firefight in Gaza.
Sinwar orchestrated an assault that killed about 1,200 people and led to the abduction of over 200 others.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Eliminated: Yahya Sinwar.
&mdash; Israel Defense Forces (@IDF) <a href="https://twitter.com/IDF/status/1846957737487278263?ref_src=twsrc%5Etfw">October 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In a prepared <a href="https://www.whitehouse.gov/briefing-room/statements-releases/2024/10/17/statement-from-president-joe-biden-on-the-death-of-yahya-sinwar/">statement</a>, President Joe Biden said the IDF &#8220;relentlessly pursued Hamas's leaders&#8221; with the help of U.S. intelligence.
&#8220;There has rarely been a military campaign like this, with Hamas leaders living and moving through hundreds of miles of tunnels, organized in multiple stories underground, determined to protect themselves with no care for the civilians suffering above ground,&#8221; Biden said. 
&#8220;Today, however, proves once again that no terrorists anywhere in the world can escape justice, no matter how long it takes.&#8221;
Sinwar's body was retrieved after an exchange of fire on Wednesday, according to the <a href="https://www.nytimes.com/live/2024/10/17/world/israel-lebanon-iran-gaza-news?campaign_id=190&amp;emc=edit_ufn_20241017&amp;instance_id=137113&amp;nl=from-the-times&amp;regi_id=136109156&amp;segment_id=180692&amp;user_id=e415429009fa21c5b8b4141c24d72bca">New York Times</a>, citing Israeli authorities. His identity was verified using dental records and fingerprints that matched those on file, Israel Police said. There was no immediate response from Hamas regarding his death.
See Also: <a href="https://www.benzinga.com/news/24/10/41112728/us-boosts-military-presence-in-middle-east-deploys-fighter-squadrons-amid-rising-tensions-with-iran">US Boosts Military Presence In Middle East As Tensions Spike With Iran</a> 
Why It Matters: Sinwar's killing marks a significant development in the yearlong conflict. 
So far, the war in Gaza devastated the region and its people. Despite being only 141 square miles, Gaza is home to over 2 million people. 
Gaza's health ministry reports over 41,000 deaths. Per the Associated Press, Gaza's health ministry <a href="https://apnews.com/article/israel-hamas-war-gaza-health-ministry-health-death-toll-59470820308b31f1faf73c703400b033">doesn't distinguish between civilians and combatants</a>. About 1.9 million Palestinians have been <a href="https://apnews.com/article/israel-palestinians-hamas-war-anniversary-statistics-e61765035c725b3c8d4840e2bab565cd">displaced</a>.
Sinwar&#8217;s death also presents an &#8220;opportunity&#8221; to proceed with negotiations between Israel and Hamas and end the war, Vice President Kamala Harris said, per <a href="https://www.bloomberg.com/news/articles/2024-10-17/harris-says-sinwar-s-death-offers-opportunity-to-end-gaza-war?srnd=phx-latest&amp;sref=TBDibEcD&amp;embedded-checkout=true">Bloomberg</a>. 
Both sides remain deadlocked over key issues. 
Israeli Prime Minister Benjamin Netanyahu addressed the nation and promised the Israeli military would secure the release of all hostages. See below for coverage via CNN.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Reporter on what he found interesting from Netanyahu's remarks" width="500" height="281" src="https://www.youtube.com/embed/8hrXuXFzUjA?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Defense exchange-traded funds (ETFs) at last check Thursday afternoon, were trending up with the exception of the SPDR S&amp;P Aerospace &amp; Defense ETF:
<ul>
<li>IShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>) rose 1.8% to $154.70.</li>
<li>Invesco Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPA#NYSE">PPA</a>) is up 0.17% to $119.</li>
<li>SPDR S&amp;P Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XAR#NYSE">XAR</a>) is down 0.29% to $162.77.</li>
</ul>
Oil ETFs: 
<ul>
<li>The United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>), was up 0.15% at $72.51.</li>
<li>The VanEck Oil Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OIH#NYSE">OIH</a>) was down 0.25% at $286.69.</li>
</ul>
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/10/41336413/oil-prices-take-largest-plunge-in-over-a-year-as-israel-vows-to-spare-iranian-facilities-energy-stoc">Oil Prices Take Largest Plunge In Over A Year As Israel Vows To Spare Iranian Facilities</a></li>
</ul>
Image: Shutterstock.

Sector ETFs

Politics

Global

iShares Dow Jones US Aerospace & Defense Index Fund

Israeli Military, With Help Of US Intelligence, 'Relentlessly Pursued' Deceased Hamas Leader

Imperial College London's Center for Psychedelic Research is recruiting couples who plan to consume <a href="https://www.benzinga.com/topic/mdma-assisted-therapy">MDMA</a> or other <a href="https://www.benzinga.com/markets/psychedelics">psychedelics</a> in real-world settings for a study examining the effects on relationship intimacy, attachment and <a href="https://www.benzinga.com/markets/cannabis/24/02/37124528/can-psychedelics-increase-sexual-interest-and-satisfaction-study-says-yes-and-effects-can-last-m">satisfaction</a>. As DoubleBlind <a href="https://doubleblindmag.com/psychedelics-for-your-relationship/">reported</a>, the study will explore both the short- and long-term psychological impacts of shared psychedelic experiences between romantic partners.
<h3 class="wp-block-heading">Study Focus: Intimacy, Attachment, and Relationship Satisfaction</h3>
The <a href="https://pubmed.ncbi.nlm.nih.gov/35031922/">research</a>, led by PhD candidate Tommaso Barba will build on <a href="https://www.researchgate.net/publication/20275204_Subjective_Reports_of_the_Effects_of_MDMA_in_a_Clinical_Setting">previous studies</a> that suggest MDMA may enhance communication and improve relationship dynamics. Participants will complete a series of <a href="https://survey.alchemer.eu/s3/90617328/Psychedelics-and-Couples-Sign-up">questionnaires</a> before and after their psychedelic experiences, but no substances will be provided as part of the study.
Couples will have the chance to contribute valuable insights to growing scientific interest in how psychedelics can affect romantic relationships, including their potential to improve communication and resolve conflicts. 
<h3 class="wp-block-heading">Why This Research Matters: Enhancing Communication And Addressing Conflict</h3>
"Another promising research direction involves addressing specific relationship issues, including communication breakdowns, unresolved conflicts and intimacy barriers,&#8221; Barba told DoubleBlind. &#8220;By leveraging the empathogenic effects of substances like <a href="https://www.benzinga.com/topic/psilocybin">psilocybin</a> and MDMA, researchers aim to develop tailored interventions that safely and effectively address these issues within a supportive therapeutic environment."
Albert Garcia-Romeu, an assistant professor of psychiatry and behavioral sciences at Johns Hopkins Medicine, <a href="https://time.com/6262291/psychedelics-mdma-couples-therapy/">told</a> TIME that "If there's a long-held resentment or disagreement in a couple and people are too hurt or too wounded or too guarded to talk about that, but then you're able to use the drug to temporarily get guards down … that can really help clear out a lot of emotional baggage."
Beyond the positive outlook, therapists have cautioned that <a href="https://www.benzinga.com/topic/psychedelic-assisted-therapies">psychedelic-assisted therapy</a> is not a quick fix and requires active participation from both partners in what can be a difficult process. Notably, MDMA is thought to evoke temporary feelings of love, which might bond dysfunctional couples but could also lead to unresolved issues resurfacing later on, or even accelerating break-ups.
Cover image made with AI

Psychedelics

How Psychedelic Experiences Affect Couples: New Study Looks Into It

Scilex Holding Company (SCLX) has provided an update. Scilex Holding Company's subsidiary and Sorrento Therapeutics filed a lawsuit alleging breach...

Scilex Holding Settles Lawsuit, Continues Litigation Against Ex-President

Scilex Holding files to sell up to 3.5M shares by holders

The latest announcement is out from Scilex Holding Company (SCLX). Scilex Holding Company has enhanced its Board of Directors by appointing Dr. Ann...

Scilex Holding Bolsters Board with Dr. Navani's Appointment

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Scilex Holding (NASDAQ:<a href="https://investorplace.com/stock-quotes/sclx-stock-quote/">SCLX</a>) just reported results for the second quarter of 2024.<ul><li>Scilex Holding reported earnings per share of -31 cents. This was below the analyst estimate for EPS of -20 cents.</li><li>The company reported revenue of $16.37 million.</li><li>This was 24.30% better than the analyst estimate for revenue of $13.17 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/sclx-stock-earnings-scilex-holding-for-q2-of-2024/">SCLX Stock Earnings: Scilex Holding Misses EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SCLX Stock Earnings: Scilex Holding Misses EPS, Beats Revenue for Q2 2024

Scilex Holding Company (SCLX) just unveiled an announcement. Semnur Pharmaceuticals has entered into a merger agreement with Denali Capital Acquisi...

Scilex's Semnur Pharmaceuticals Set for Strategic Merger with Denali

Scilex Holding Company ( ($SCLX) ) has issued an update. Scilex Holding Company has reached an agreement with Endeavor Distribution LLC to satisfy ...

Scilex Settles Debt, Expands Distribution of Non-Opioid Treatments

Scilex Holding Company ( ($SCLX) ) has shared an announcement. Scilex Holding Company has successfully entered into a registered convertible financ...

Scilex Holding Secures $50M for Debt Restructuring and Growth

Denali Capital Acquisition Corp. announces extension of deadline to complete business combination

Warning: SCLX is at high risk of performing badly

Scilex gains on spinoff plans for pharma subsidiary

DECA

SCLX

Skyscrapers,Cityscape,Downtown,View,,Nashville,Skyline,Buildings.,Beautiful,Real,Estate.

Press Releases

Scilex Holding Company Announces Signing Of A $50 Million Registered Convertible Financing To Refinance And Restructure Existing Debt &amp; Further Strengthens Financial Profile

United,States,Bankruptcy,Court,Sign

Biotech

SRNEQ

Scilex Holding Company Announces That The U.S. Bankruptcy Court Has Extended The Lockup Period On Shares Of Scilex Dividend Stock Previously Distributed By Sorrento To Its Stockholders As A Dividend To January 31, 2025

Business,Analyst,Checking,In,Financial,Statement,For,Audit,Internal,Control

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended July 31, 2024

Hand,Of,Human,Holding,Crystal,Globe,Ball,With,Tree,For

Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report

Business,Man,Sign,A,Contract,Investment,Professional,Document,Agreement.,Meeting

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

Businessmen,Making,Handshake,With,Partner,,Greeting,,Dealing,,Merger,And,Acquisition,

Scilex Holding Company Partners With New National Distributor, Endeavor Distribution LLC.

Muscular,Man,Suffering,From,Back,And,Neck,Pain.,Incorrect,Sitting

Scilex Holding Company Announces Publication In PAIN Journal Regarding Phase 3 Results Of The Pivotal Registration Trial Of SP-102 (SEMDEXA™) In Lumbosacral Radicular Pain (Sciatica)

Outside,Of,Logistics,Warehouse,With,Open,Door,,Delivery,Van,Loaded

Scilex Holding Company Announces That Many National Pharmacy Chains And Independent Pharmacies Have Begun Stocking GLOPERBA®

Interior,Of,A,Modern,Warehouse,Storage,Of,Retail,Shop,With

Scilex Holding Company Announces Stocking Of GLOPERBA® Is Underway In All Of The Wholesalers With Which Scilex Has Stocking Arrangements Throughout The U.S.

Man,Writing,Text,Document,,Essay,Or,Letter,With,Laptop.,Freelance

Scilex Holding Company Sends Letters To The U.S. Securities And Exchange Commission And Financial Industry Regulatory Authority Regarding Illegal Market Manipulation Of The Common Stock Of Scilex Holding Company

Scilex Holding Company Announces the Continuing Support from Endeavor Distribution LLC in the Multi-Year Agreement for Scilex's Commercial Products and the Satisfaction of FSF 33433 LLC $10 Million Loan

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to January 31, 2025

Financing

Scilex Holding Company Announces Signing of a $50 Million Registered Convertible Financing to Refinance and Restructure Existing Debt & Further Strengthens Financial Profile

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt

Scilex Holding Company Announces Closing of a $50 Million Registered Convertible Financing

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 Billion

Management

Scilex Holding Company Announces that its Board of Directors has Authorized Management to Explore Ways to Maximize the Value of its Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., including by way of conducting a spinoff or public listing of securities of Scilex Pharmaceuticals Inc. Scilex Pharmaceuticals Commercial Products Include Three Non-Opioid Approved Products and Pipeline of Phase 3 Ready SP-103 With Greater Than a $1.0 Billion Revenue Potential

Comments

Scilex Holding

Noticias

Últimas noticias sobre Scilex Holding (NASDAQ:SCLX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL